Stay updated on Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Core page content identifying investigators, sponsor, collaborators, and other study personnel was removed, along with multiple study record metadata sections. A new Revision: v3.6.5 tag appears, indicating a version update to the page.
    Difference
    17%
    Check dated 2026-08-08T18:14:23.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.3 to v3.6.4, indicating a new deployment. This update does not modify the study details or functionality presented to users.
    Difference
    0.1%
    Check dated 2026-07-25T12:29:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.2 to v3.6.3. This represents a routine update that does not alter study information or how a user interacts with the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:55:39.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0; this indicates a new build of the page template rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T01:49:45.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    A recruitment status line indicating no participant enrollment was added. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Interventional label formatting was refined from 'Intervention / Treatment' to 'Intervention/Treatment', and a site revision stamp 'Revision: v3.6.0' was introduced.
    Difference
    0.6%
    Check dated 2026-06-12T16:11:36.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This reflects a metadata version bump for the study page rather than any substantive alteration to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T09:56:49.000Z thumbnail image

Stay in the know with updates to Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.